blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2697195

EP2697195 - PHENYL BICYCLIC METHYL AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.10.2015
Database last updated on 29.10.2024
Most recent event   Tooltip02.10.2015Application deemed to be withdrawnpublished on 04.11.2015  [2015/45]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2014/08]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, California 92886 / US
Inventor(s)01 / TAKEUCHI, Janet A.
8195 E. Bailey Way
Anaheim California 92808 / US
02 / LI, Ling
52 Marlehead
Irvine California 92620 / US
03 / IM, Wha Bin
70 Palatine, Apt. 305
Irvine California 92612 / US
 [2014/08]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2014/08]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12717532.112.04.2012
WO2012US33299
Priority number, dateUS201161475346P14.04.2011         Original published format: US 201161475346 P
[2014/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012142268
Date:18.10.2012
Language:EN
[2012/42]
Type: A1 Application with search report 
No.:EP2697195
Date:19.02.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2012 takes the place of the publication of the European patent application.
[2014/08]
Search report(s)International search report - published on:EP18.10.2012
ClassificationIPC:C07D205/04, A61K31/397, A61P37/00
[2014/08]
CPC:
C07D205/04 (EP,US); C07D403/06 (US); A61P1/00 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P19/10 (EP); A61P25/00 (EP); A61P25/28 (EP);
A61P27/00 (EP); A61P27/06 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/08 (EP); A61P9/10 (EP);
C07D401/06 (EP,US); C07D405/06 (EP,US); C07D409/06 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/08]
TitleGerman:BICYCLISCHE PHENYLMETHYLAZETIDINDERIVATE ALS SPHINGOSIN-1-PHOSPHATREZEPTORMODULATOREN[2014/08]
English:PHENYL BICYCLIC METHYL AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS[2014/08]
French:DÉRIVÉS DE MÉTHYLAZÉTIDINES BICYCLIQUES PHÉNYLIQUES EN TANT QUE MODULATEURS DES RÉCEPTEURS DE SPHINGOSINE-1 PHOSPHATE[2014/08]
Entry into regional phase06.11.2013National basic fee paid 
06.11.2013Designation fee(s) paid 
06.11.2013Examination fee paid 
Examination procedure06.11.2013Examination requested  [2014/08]
05.12.2014Communication of intention to grant the patent
16.04.2015Application deemed to be withdrawn, date of legal effect  [2015/45]
29.05.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/45]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.12.2014
Fees paidRenewal fee
28.04.2014Renewal fee patent year 03
27.04.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2010043000  (AKAAL PHARMA PTY LTD [AU], et al) [A] 1-11 * examples 2, 25, 27, 29-31, 34 *;
 [A]WO2010093704  (ABBOTT LAB [US], et al) [A] 1-11* the whole document *
by applicant   - PURE APPLI. CHEM., (1976), vol. 45, pages 11 - 13
    - Handbook of Pharmaceutical Salts, VERLAG HELVETICA CHEMICA ACTA- ZURICH, (2002), pages 329 - 345
    - Handbook of Pharmaceutical Salts, VERLAG HELVETICA CHEMICA ACTA, (2002), pages 329 - 345
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.